Abstract:BackgroundThe discovery of androgen receptor (AR) having transrepression effects completes the circle of its functionalities as a typical transcription factor, which intrinsically bears dual functions of activation and repression linked to co-factor competition and redistribution. Indeed, AR dual functions are exemplified by locus-wide regulation of the oncogenic 8q24-MYC region. MethodsRT-qPCR assay and public RNA-profiling datasets were used to assess MYC transcription in androgen-sensitive cell lines. Public ChIP-seq and RNA-Seq datasets were computed to evaluate AR-MYC direct and indirect signatures. Gene sets in typical MYC and AR pathways were monitored to validate their cross-talks. Bio-informatics and chromosome conformation capture (3C) assay were performed in the AR gene locus to examine androgen-elicited distal regulation. Finally, co-factor re-distribution were globally tracked between AR and MYC binding sites. ResultsIn this report, we found MYC responded negatively to androgen with hypersensitivity, rivaling AR natural functions as an innate androgen effector. Furthermore, both direct and indirect AR and MYC transcriptional programs were actively in equilibration. With established androgen-mediated versus MYC-mediated gene subsets, we validated AR and MYC pathways were both bidirectional and extensively entangled. In addition, we determined that the AR gene locus resembled the MYC gene region and both loci were androgen-repressed via epigenetics and chromatin architectural alterations. Significantly, transcriptional factor profiling along the prostate cancer (PCa) genome exposed that PCa transcriptomes were dynamically equilibrated between AR-binding site and MYC-binding site. ConclusionTogether, our findings stratified AR-MYC interactions that are extensively wired and intricately organized to compensate for essential PCa transcriptional programs and neutralize excessive signaling.

Amplitude modulation of androgen signaling by c-MYC.

Androgen Receptor and MYC Transcriptomes Are Equilibrated in Multilayer Regulatory Circuitries in Prostate Cancer

A Positive Role of C-Myc in Regulating Androgen Receptor and Its Splice Variants in Prostate Cancer

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer

MYC dysfunction modulates stemness and tumorigenesis in breast cancer

MYC reshapes CTCF-mediated chromatin architecture in prostate cancer

Targeting Molecular Signaling Pathways and Cytokine Responses to Modulate c-MYC in Acute Myeloid Leukemia

Hbxip And Lsd1 Scaffolded By Lncrna Hotair Mediate Transcriptional Activation By C-Myc

Pharmacological Targeting of MYC-regulated IRE1/XBP1 Pathway Suppresses MYC-driven Breast Cancer

A Positive Feedback Loop Between EBP2 and C-Myc Regulates Rdna Transcription, Cell Proliferation, and Tumorigenesis.

c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies.

Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis

c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment

Transcriptional Amplification in Tumor Cells with Elevated c-Myc

Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Regulation

Cancer-cell-secreted Exosomal Mir-105 Promotes Tumour Growth Through the MYC-dependent Metabolic Reprogramming of Stromal Cells

A Novel Oncogenic Enhancer of Estrogen Receptor-Positive Breast Cancer.

Menin Enhances C-Myc-mediated Transcription to Promote Cancer Progression

Androgen stimulation rapidly reorganizes temporal 3D genome and epigenome states to trigger AR-mediated transcription in prostate cancer.

B-Raf Activation Cooperates with Pten Loss to Drive C-Myc Expression in Advanced Prostate Cancer

Abstract B121: Oncogenic MYC Contributes to Tumor Super-Enhancers Via Erna Amplification